Your browser doesn't support javascript.
loading
BMP4 drives primed to naïve transition through PGC-like state.
Yu, Shengyong; Zhou, Chunhua; He, Jiangping; Yao, Zhaokai; Huang, Xingnan; Rong, Bowen; Zhu, Hong; Wang, Shijie; Chen, Shuyan; Wang, Xialian; Cai, Baomei; Zhao, Guoqing; Chen, Yuhan; Xiao, Lizhan; Liu, He; Qin, Yue; Guo, Jing; Wu, Haokaifeng; Zhang, Zhen; Zhang, Man; Zhao, Xiaoyang; Lan, Fei; Wang, Yixuan; Chen, Jiekai; Cao, Shangtao; Pei, Duanqing; Liu, Jing.
Afiliação
  • Yu S; Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
  • Zhou C; Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
  • He J; Center for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.
  • Yao Z; State Key Laboratory of Organ Failure Research, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Huang X; Laboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, 310024, China.
  • Rong B; Shanghai Key Laboratory of Medical Epigenetics, State International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, F
  • Zhu H; Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
  • Wang S; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Chen S; GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, 511436, China.
  • Wang X; Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
  • Cai B; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Zhao G; GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, 511436, China.
  • Chen Y; Center for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.
  • Xiao L; Center for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.
  • Liu H; State Key Laboratory of Organ Failure Research, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Qin Y; Center for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.
  • Guo J; Center for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.
  • Wu H; Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
  • Zhang Z; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Zhang M; Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
  • Zhao X; Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
  • Lan F; Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
  • Wang Y; Center for Cell Lineage and Atlas, Bioland Laboratory, 510005, Guangzhou, China.
  • Chen J; State Key Laboratory of Organ Failure Research, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Cao S; Shanghai Key Laboratory of Medical Epigenetics, State International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, F
  • Pei D; Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
  • Liu J; School of Life Sciences, University of Science and Technology of China, Hefei, 230026, China.
Nat Commun ; 13(1): 2756, 2022 05 19.
Article em En | MEDLINE | ID: mdl-35589713
ABSTRACT
Multiple pluripotent states have been described in mouse and human stem cells. Here, we apply single-cell RNA-seq to a newly established BMP4 induced mouse primed to naïve transition (BiPNT) system and show that the reset is not a direct reversal of cell fate but goes through a primordial germ cell-like cells (PGCLCs) state. We first show that epiblast stem cells bifurcate into c-Kit+ naïve and c-Kit- trophoblast-like cells, among which, the naïve branch undergoes further transition through a PGCLCs intermediate capable of spermatogenesis in vivo. Mechanistically, we show that DOT1L inhibition permits the transition from primed pluripotency to PGCLCs in part by facilitating the loss of H3K79me2 from Gata3/6. In addition, Prdm1/Blimp1 is required for PGCLCs and naïve cells, while Gata2 inhibits PGC-like state by promoting trophoblast-like fate. Our work not only reveals an alternative route for primed to naïve transition, but also gains insight into germ cell development.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Germinativas / Camadas Germinativas Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Germinativas / Camadas Germinativas Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China